HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis

被引:177
作者
Stokkers, PCF [1 ]
Reitsma, PH [1 ]
Tytgat, GNJ [1 ]
van Deventer, SJH [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Lab Expt Internal Med, NL-1105 AZ Amsterdam, Netherlands
关键词
ulcerative colitis; Crohn's disease; HLA-DR; HLA-DQ;
D O I
10.1136/gut.45.3.395
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background-Susceptibility to inflammatory bowel disease (IBD) is partially genetically determined and the HLA class II genes are candidates for a role in genetic susceptibility to IBD, because their products play a central role in the immune response. Multiple studies have reported associations between HLA-DR or -DQ phenotypes and either ulcerative colitis or Crohn's disease, but much of the data are still controversial. Aims-To estimate overall associations between HLA class II phenotypes and IBD, and to establish the relative risk conferred by HLA-DR and -DQ phenotypes by meta-analysis, Methods-Medline was searched for publications reporting on the relation between IBD and HLA class II phenotypes. Raw data were extracted by recalculating the number of phenotypes or the number of alleles of the main antigens. Odds ratios and confidence intervals were calculated according to the Mantel-Haenszel method. Results-DR2, DR9, and DRB1*0103 were positively associated with ulcerative colitis, and a negative association was found for DR4 and ulcerative colitis. For Crohn's disease a positive association was found with DR7, DRB3(star)0301, and DQ4 and a negative association with DR2 and DR3. Conclusions-Both ulcerative colitis and Crohn's disease are associated with specific HLA class II phenotypes. Further analysis of these phenotypes and subgroup analysis may elucidate how these alleles contribute to susceptibility to IBD.
引用
收藏
页码:395 / 401
页数:7
相关论文
共 48 条
  • [21] OLIGONUCLEOTIDE GENOTYPING SHOWS THAT ALLELES AT THE HLA-DR-BETA-III LOCUS OF THE DRW52 SUPERTYPIC GROUP SEGREGATE INDEPENDENTLY OF KNOWN DR OR DW SPECIFICITIES
    GORSKI, J
    TILANUS, M
    GIPHART, M
    MACH, B
    [J]. IMMUNOGENETICS, 1987, 25 (02) : 79 - 83
  • [22] THE EPIDEMIOLOGIC APPROACH TO STUDIES OF ASSOCIATION BETWEEN HLA AND DISEASE .2. ESTIMATION OF ABSOLUTE RISKS, ETIOLOGIC AND PREVENTIVE FRACTION
    GREEN, A
    [J]. TISSUE ANTIGENS, 1982, 19 (04): : 259 - 268
  • [23] THE EPIDEMIOLOGIC APPROACH TO STUDIES OF ASSOCIATION BETWEEN HLA AND DISEASE .1. THE BASIC MEASURES, CONCEPTS AND ESTIMATION PROCEDURES
    GREEN, A
    [J]. TISSUE ANTIGENS, 1982, 19 (04): : 245 - 258
  • [24] Heresbach D, 1996, AM J GASTROENTEROL, V91, P1060
  • [25] HERESBACH D, 1996, EUR J IMMUNOGENET, V23, P141
  • [26] Mapping of a susceptibility locus for Crohn's disease on chromosome 16
    Hugot, JP
    LaurentPuig, P
    GowerRousseau, C
    Olson, JM
    Lee, JC
    Beaugerie, L
    Naom, I
    Dupas, JL
    VanGossum, A
    Orholm, M
    BonaitiPellie, C
    Weissenbach, J
    Mathew, CG
    LennardJones, JE
    Cortot, A
    Colombel, JF
    Thomas, G
    [J]. NATURE, 1996, 379 (6568) : 821 - 823
  • [27] 3-DIMENSIONAL STRUCTURE OF A HUMAN CLASS-II HISTOCOMPATIBILITY MOLECULE COMPLEXED WITH SUPERANTIGEN
    JARDETZKY, TS
    BROWN, JH
    GORGA, JC
    STERN, LJ
    URBAN, RG
    CHI, YI
    STAUFFACHER, C
    STROMINGER, JL
    WILEY, DC
    [J]. NATURE, 1994, 368 (6473) : 711 - 718
  • [28] KOBAYASHI K, 1990, EXP CLIN IMMUNOGENET, V7, P101
  • [29] KOBAYASHI K, 1990, CLIN EXP IMMUNOL, V80, P400
  • [30] HLA ANTIGENS IN ULCERATIVE-COLITIS AND PRIMARY SCLEROSING CHOLANGITIS
    LEIDENIUS, MHK
    KOSKIMIES, SA
    KELLOKUMPU, IH
    HOCKERSTEDT, KAV
    [J]. APMIS, 1995, 103 (7-8) : 519 - 524